MedTrace Logo

The Mental Health Effects of a Mindfulness App in Parents of a Child With Medical Complexity

NCT05925868 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2023-12-01

No results posted yet for this study

Summary

The number of children with special health care needs (CSHCN) in the US is nearly 20% of children representing approximately 14.6 million children nationally. A subgroup of CSHCN are children who have the most intensive healthcare needs known as children with a medical complexity (CMC). Parents of CMC experience many challenges. In addition to typical caregiver tasks, parents of a CMC may experience added stress and are more likely to experience higher rates of anxiety, depression, and post-traumatic stress disorder than parents of healthy children. This project aims to explore the acceptability and feasibility of a mindfulness mobile application for parents of a CMC as well as determine the effectiveness of mindfulness application use on stress, depression, and family management in parents of a CMC. Forty-five participants will be recruited and given access to a mindfulness application and instructed to use it at least 4 days a week for at least 10 minutes. Parents will fill out questionnaires on app usage, as well as stress, depression, and family management. This work will be accomplished through a pilot single arm approach.

Conditions

  • Depression
  • Family Dynamics
  • Stress, Psychological
  • Chronic Illness
  • Parents

Interventions

BEHAVIORAL

mindfulness app

Parents will use the mindfulness app, Headspace, for at least 10 minutes on 4 days/week.

Sponsors & Collaborators

  • Case Western Reserve University

    collaborator OTHER

  • Boise State University

    lead OTHER

Principal Investigators

  • Cara Gallegos, PhD, BSN · Boise State University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-11-23
Completion
2023-11-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05925868 on ClinicalTrials.gov